DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Infosys Share Price Live Updates: Infosys Bonus Updates

Economic Times 7 hrs ago·10 Sept 2026, 4:25 am

Infosys has announced a bonus share issue, allowing existing shareholders to receive additional shares for free. This move increases the total number of shares outstanding without requiring any additional payment from investors.

This decision is generally viewed positively by the market as it enhances the liquidity of the stock and can make it more accessible to a wider range of investors. It also signals the company's confidence in its future growth and financial health.

Investors should check their Demat accounts to see if the bonus shares have been credited. While this action does not directly impact the company's underlying value, it can lead to a temporary increase in trading volume and price volatility.